Tune Therapeutics

Focus: Tune Therapeutics is an early-stage biotech company focused on epigenetic modification to modulate gene expression, primarily targeting rare diseases. The company is pre-revenue with a single Phase 1 program and minimal public visibility.

Rare Diseases

Profile data last refreshed 17h ago · AI intelligence enriched 2w ago

Open Jobs

About Tune Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow Tune Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Tune-401

Chronic Hep B

PHASE_1

Clinical Trials (1)

NCT06671093Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

Phase 1

Help build intelligence for Tune Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pioneering epigenetic platform with potential for transformative approaches in underserved rare disease markets
Ground-floor opportunity at a focused biotech company with defensible IP in an emerging therapeutic modality
Based in Durham, NC (Research Triangle), a growing biotech hub with access to academic partnerships

Watch Out For

Extremely early stage (Phase 1 only) with no data readouts, revenue, or commercial proof-of-concept
Minimal hiring activity (1 active role) and unknown funding/cash position suggest limited near-term expansion
No published literature or public milestones available, raising questions about scientific validation and progress

Generated by Claude from Tune Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 1 clinical trial

Top TAs: Infectious Diseases

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Infectious Diseases

1 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles